Uncommon Descent Serving The Intelligent Design Community

Revisit: Unified theory of evolution, 2016

Of course. Michael Skinner, a Washington State U biology prof, makes good sense. But no, nothing happens. Too many fossils in Darwin world now. They just want dusting off now and then. And, in a world of change, they also expect things to continue that way… Read More ›

On Scientific Methods and alternatives to the “Placebo Control is the gold standard” view, in the face of pandemics (–> Logic & First Principles, 38)

It is clear that we need to re-think how we go about doing science to warrant approaches to the pandemic. So, allow me to headline a comment from the double-blind thread: KF, 16: >> I am also thinking back to the old “Scientific Method” summary we were taught in schools and its roots in Newton’s Opticks, Query 31: As in Mathematicks, so in Natural Philosophy, the Investigation of difficult Things by the Method of Analysis, ought ever to precede the Method of Composition. This Analysis consists in making Experiments and Observations, and in drawing general Conclusions from them by Induction, and admitting of no Objections against the Conclusions, but such as are taken from Experiments, or other certain Truths. For Read More ›

Classic “evolution” rubbish about COVID-19

So the worry is that we are more social than chimps and therefore can’t handle social distancing? Seriously, the big difference between being a human and being a chimp is that humans can actually decide to do something based on reason. It comes of having an intellect, something Darwinian evolution has never been able to assimilate. Read More ›

BREAKING: Stanford Study: COVID-19 Case Fatality Rate May be Overstated by a factor of 85

As we have discussed in these pages, the CFR (case fatality rate) for COVID-19 is extremely difficult to calculate. We have a rough estimate of the numerator (deaths). But even that may be off, because of the difference between dying “with” COVID-19 and dying “of” COVID-19. In other words, if a person who was going to die of cancer today anyway gets COVID-19 an hour before he dies, is it correct to say he died of the virus just because he had it when he died. This is not theoretical. The Health Minister of Italy said the virus fatality number in his country is certainly overstated for this reason. For all the problems the numerator has, they pale in comparison Read More ›

Time to End One-Size-Fits-All Virus Response

Trump’s plan calls for protecting vulnerable age cohorts while letting the less vulnerable get back to work. The two charts below demonstrate why opposition to this proposal borders on the insane. The first chart is from CDC’s website showing COVID-19 deaths by age cohort as of April 17. The total is only 13,130, because CDC is behind in sorting this data. According to Worldmeter, total US deaths as of April 17 are 37,230. The second chart assumes the rates stay the same as the data is compiled (and I see no reason we should not assume that). Then I calculate total deaths as of today by age cohort. One number should jump out at you. 3,315. That is the total number Read More ›

H’mm, Remdesivir may be promising . . .

I am seeing a report: Gilead Science’s experimental antiviral medicine remdesivir is reportedly showing promise for the treatment of people plagued with the novel coronavirus, with nearly all patients in a closely monitored clinical trial at a Chicago hospital discharged in just days, an early assessment of data released this week revealed . . . . STAT, a medical news outlet, first reported that an early peek at the data from the clinical trial in Chicago suggested that coronavirus patients were responding to the Gilead Science drug. “The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the Read More ›

Guardian exemplifies the placebo control gold standard fallacy (–> being, Logic and First Principles, 37)

Shortly after I posted yesterday on whether placebo based studies are properly a gold standard, one of our common objectors, JT, linked the Guardian. Perhaps, he did not realise just how aptly it illustrates my point. I therefore responded, as I now headline as a shop window case- in- point illustration of what is going wrong with medical testing, linked statistics and linked ethics . . . not to mention, too much of the media and the way we tend to think: This is part of why I have written as I have in the OP: [Guardian, annotated:] >>The French doctor Didier Raoult has claimed [–> has reported, on now almost 3,000 patients, under a test protocol approved by relevant Read More ›

At Nature: Evolutionary trees can’t reveal speciation and extinction rates

New paper poses a serious challenge to the schoolroom Darwin industry. You know, one day, the study of evolution might be interesting, like the study of history. Prying the Darwin lobby and its propaganda loose from positions of power is a necessary first step. Read More ›

Has any “thinking machine” passed the Lovelace test?

Surprising results from computer programs do not equate to creativity, says computer scientist Selmer Bringsjord. Is there such a thing as machine creativity? The feats of machines like AlphaGo are due to superior computational power, not to creativity at originating new ideas. Computer scientist Selmer Bringsjord sees the ability to write, say, a novel of ideas as a more realistic test of human vs. computer achievement. “And probably the world’s leading authority on musical creativity, David Cope, does say explicitly that if the machine can do problem-solving, it catches people by surprise, he would stick to his guns and say that’s creative. I absolutely reject that notion. I think the next step up is MacGuyver creativity—what I called N creativity Read More ›

Are double-blind placebo-controlled studies the rightful “gold standard”? (So that, whatever does not “measure up” can be discounted or dismissed?)

As we have seen in recent weeks as Covid-19 and Hydrochloroquine cocktail treatments have been on the table, there is a clear tendency to view and treat double-blind placebo controlled testing as a “gold standard” yardstick and to then use such to discount and dismiss whatever does not “measure up” such as Professor Raoult’s work over in France. I will now argue in outline that such an attitude is selectively hyperskeptical, seriously ethically, epistemologically and logically flawed, and sets up a crooked yardstick. It is a commonplace in Medical research that arguably more lives were saved, net, than perished through the tainted medical studies in the Nazi death camps. However, the taint was seen as so serious that a programme Read More ›